tm logo
JEMGALITY
ABANDONED SECTION 36

on 09 Dec 2020

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1837967 filed on 16th May 2017

JEMGALITY

Trademark usage description

pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alzheimer's, anxiety disorders, atherosclerosis, autoimmune dise Read More

Classification Information


Class [005]
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hormonal diseases and disorders, namely vasomotor symptoms and hot flashes, inflammation and inflammatory diseases and disorders, namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, namely metabolic syndrome, migraines, muscle diseases and disorders, namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders, namely Huntington's disease, Alzheimer's disease, Dementia and Parkinson's disease, neurological disorders namely, Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, pancreatic diseases and disorders, psychiatric disorders, namely acute stress disorder, substance abuse, delusions and hallucinations, sleep disorders, urological disorders; antidepressants; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases


Classification kind code

11

Mark Details


Serial Number

1837967

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 21st Nov 2018
Allowed
Submitted for opposition 51
on 21st Nov 2018
Allowance Notice Sent
Submitted for opposition 42
on 08th Aug 2018
Advertised
Submitted for opposition 26
on 19th Jul 2018
Approved
Submitted for opposition 27
on 28th May 2018
Approval Notice Sent
Submitted for opposition 22
on 15th Sep 2017
Search Recorded
Submitted for opposition 20
on 15th Sep 2017
Examiner's First Report
Submitted for opposition 31
on 23rd May 2017
Formalized
Submitted for opposition 1
on 17th May 2017
Created
Submitted for opposition 30
on 16th May 2017
Filed